Date Filed | Type | Description |
10/12/2023 |
8-K
| Quarterly results |
08/10/2023 |
8-K
| Quarterly results |
07/21/2023 |
8-K
| Quarterly results |
05/26/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
05/11/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
05/09/2023 |
8-K
| Other Events Interactive Data |
05/01/2023 |
8-K
| Quarterly results |
04/20/2023 |
8-K
| Quarterly results |
04/06/2023 |
8-K
| Other Events Interactive Data |
03/23/2023 |
8-K
| Other Events Interactive Data |
03/21/2023 |
8-K
| Quarterly results
Docs:
|
"Evoke Pharma Reports Fourth Quarter and Full Year 2022 Financial Results Fiscal year 2022 net product sales from prescriptions increased by 179% to $2.5 million versus 2021 Patient enrollment increased by 149% compared with 2021 SOLANA BEACH, Calif., March 21, 2023 -- Evoke Pharma, Inc. , a specialty pharmaceutical company focused primarily on treatments for gastrointestinal diseases with an emphasis on GIMOTI® nasal spray, today announced its financial results for the fourth quarter and full year ended December 31, 2022, and recent corporate developments. “Evoke’s fiscal year 2022 was a period of tremendous growth and progress on several key fronts. Year-over-year revenues, new prescribers, prescription fills, and patient enrollments showed significant improvement in 2022 compared ..." |
|
02/13/2023 |
8-K
| Quarterly results |
01/30/2023 |
8-K
| Other Events Interactive Data |
11/30/2022 |
8-K
| Quarterly results |
11/09/2022 |
8-K
| Quarterly results |
09/20/2022 |
8-K
| Other Events Interactive Data |
08/26/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
08/10/2022 |
8-K
| Quarterly results |
06/08/2022 |
8-K
| Quarterly results |
05/23/2022 |
8-K
| Quarterly results |
05/20/2022 |
8-K
| Quarterly results |
05/10/2022 |
8-K
| Quarterly results |
04/28/2022 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
04/26/2022 |
8-K
| Other Events Interactive Data |
03/08/2022 |
8-K
| Quarterly results |
02/24/2022 |
8-K
| Quarterly results |
02/17/2022 |
8-K
| Other Events Interactive Data |
02/02/2022 |
8-K
| Quarterly results |
01/04/2022 |
8-K
| Other Events Interactive Data |
12/30/2021 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Interact... |
11/10/2021 |
8-K
| Quarterly results |
10/20/2021 |
8-K
| Other Events Interactive Data |
09/29/2021 |
8-K
| Other Events Interactive Data |
08/12/2021 |
8-K
| Quarterly results |
|